Home

Acrobatics Camel servant annkristin heine Decline Sloppy semiconductor

CIO Bonn - Lymphomzentrum
CIO Bonn - Lymphomzentrum

Researchers release the brakes on the immune | EurekAlert!
Researchers release the brakes on the immune | EurekAlert!

Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook
Krebszentrum CIO Bonn - Ich bin Prof. Annkristin Heine | Facebook

The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and  Function
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function

Bjørn Heine Strand - NIPH
Bjørn Heine Strand - NIPH

Volume 21, Issue 3, Pages (October 2017) - ppt download
Volume 21, Issue 3, Pages (October 2017) - ppt download

Team | IMMEI
Team | IMMEI

Dexamethasone induced inhibition of Dectin-1 activation of antigen  presenting cells is mediated via STAT-3 and NF-κB signaling pathways |  Scientific Reports
Dexamethasone induced inhibition of Dectin-1 activation of antigen presenting cells is mediated via STAT-3 and NF-κB signaling pathways | Scientific Reports

The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and  Function | PLOS ONE
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE

Immunotherapy as an advance in cancer medicine - Innovations Report
Immunotherapy as an advance in cancer medicine - Innovations Report

Generation and functional characterization of MDSC-like cells
Generation and functional characterization of MDSC-like cells

UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“
UKB NewsRoom | Erfolg bei Ausschreibung „Advanced Clinician Scientist“

Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook
Unter der Leitung von Frau Prof.... - Krebszentrum CIO Bonn | Facebook

Frontiers | Case report: Complete response to pembrolizumab in a liver  metastatic colon adenocarcinoma patient with a novel likely pathogenic  germline MSH2 mutation
Frontiers | Case report: Complete response to pembrolizumab in a liver metastatic colon adenocarcinoma patient with a novel likely pathogenic germline MSH2 mutation

Medicine®
Medicine®

Clinical and immunological effects of mRNA vaccines in malignant diseases |  Molecular Cancer | Full Text
Clinical and immunological effects of mRNA vaccines in malignant diseases | Molecular Cancer | Full Text

Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine +  Beisswenger Gruppe | LinkedIn
Ann-Kristin Müller – Stellvertretende Niederlassungsleiterin – Heine + Beisswenger Gruppe | LinkedIn

The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and  Function | PLOS ONE
The VEGF-Receptor Inhibitor Axitinib Impairs Dendritic Cell Phenotype and Function | PLOS ONE

UKB NewsRoom | Annkristin Heine
UKB NewsRoom | Annkristin Heine

Pacritinib protects dendritic cells more efficiently than ruxolitinib -  Experimental Hematology
Pacritinib protects dendritic cells more efficiently than ruxolitinib - Experimental Hematology

G-quadruplexes: a promising target for cancer therapy | Molecular Cancer |  Full Text
G-quadruplexes: a promising target for cancer therapy | Molecular Cancer | Full Text

Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte  Onkologie
Auszeichnung für herausragende Krebsforscher - Centrum für Integrierte Onkologie

Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces  Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell
Transfection of Dendritic Cells with in Vitro-Transcribed CMV RNA Induces Polyclonal CD8+- and CD4+-Mediated CMV-Specific T Cell

Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des  Universitätsklinikums Bonn
Prof. Dr. med. Annkristin Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn
AG Heine - Hämatologie und Onkologie des Universitätsklinikums Bonn

Annkristin HEINE | Medical Doctor | Professor | University of Bonn -  Medical Center, Bonn | Haematology Oncology | Research profile
Annkristin HEINE | Medical Doctor | Professor | University of Bonn - Medical Center, Bonn | Haematology Oncology | Research profile

The PI3Kδ inhibitor idelalisib impairs the function of human dendritic  cells | SpringerLink
The PI3Kδ inhibitor idelalisib impairs the function of human dendritic cells | SpringerLink

Team | IMMEI
Team | IMMEI